Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · IEX Real-Time Price · USD
12.75
+0.86 (7.23%)
Jul 22, 2024, 9:30 AM EDT - Market open
Perspective Therapeutics Employees
As of December 31, 2023, Perspective Therapeutics had 119 total employees, including 116 full-time and 3 part-time employees. The number of employees increased by 53 or 80.30% compared to the previous year.
Employees
119
Change
53
Growth
80.30%
Revenue / Employee
n/a
Profits / Employee
-$490,933
Market Cap
852.32M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Healthcare Services Group | 33,400 |
InnovAge Holding | 2,100 |
GeneDx Holdings | 1,000 |
Pacira BioSciences | 712 |
AbCellera Biologics | 586 |
Cronos Group | 356 |
Harrow Health | 315 |
Humacyte | 185 |
CATX News
- 2 hours ago - Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Perspective Therapeutics Announces Inclusion in the Russell 3000® Index - GlobeNewsWire
- 5 weeks ago - Perspective Therapeutics Announces 1-for-10 Reverse Stock Split - GlobeNewsWire
- 5 weeks ago - Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024 - GlobeNewsWire
- 2 months ago - Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Q1 2024 Results - GlobeNewsWire
- 2 months ago - Perspective Therapeutics to Participate at Upcoming May Investor Conferences - GlobeNewsWire